TOLERA THERAPEUTICS INC has a total of 15 patent applications. Its first patent ever was published in 2012. It filed its patents most often in United States, Australia and Brazil. Its main competitors in its focus markets pharmaceuticals and biotechnology are PROTAGONIST THERAPEUTICS INC, ALLERGENE LTD and XENOME LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 5 | |
#2 | Australia | 1 | |
#3 | Brazil | 1 | |
#4 | Canada | 1 | |
#5 | China | 1 | |
#6 | EPO (European Patent Office) | 1 | |
#7 | Hong Kong | 1 | |
#8 | Israel | 1 | |
#9 | Republic of Korea | 1 | |
#10 | Mexico | 1 | |
#11 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Peptides | |
#3 | Therapeutic chemical compounds | |
#4 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Fokta Frank J | 12 |
#2 | Herrmann James Joseph | 7 |
#3 | Getts Daniel Richardt | 7 |
#4 | Puisis John James | 7 |
#5 | Getts Daniel R | 5 |
#6 | Herrmann James J | 5 |
#7 | Puisis John J | 5 |
#8 | Frank J Fokta | 2 |
#9 | Daniel Richardt Getts | 2 |
#10 | John James Puisis | 2 |
Publication | Filing date | Title |
---|---|---|
US2013273089A1 | Antibody and methods for selective inhibition of t-cell responses | |
CN104870011A | Antibody and methods for selective inhibition of T-cell responses |